ReviewNutrients2026
Sarcopenia and Muscle Dysfunction in Older Adults with Burn Injuries: An Integrated Clinical Perspective.
Review in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcopenia is a progressive skeletal muscle disorder associated with impaired physical function and adverse outcomes in older adults. Burn injury imposes profound hypermetabolic and catabolic stress that may compromise muscle mass, strength, and physical function, particularly in individuals with reduced baseline muscle reserve. This narrative review integrates current evidence on sarcopenia and muscle dysfunction in older adults with burn injuries, addressing baseline vulnerability, burn-related muscle deterioration, diagnostic challenges, clinical implications, and therapeutic strategies. Patients may present with pre-existing sarcopenia or reduced muscle reserve, develop acute sarcopenia during or after burn-related illness, or experience worsening of pre-existing sarcopenia, potentially resulting in an acute-on-chronic trajectory. However, substantial burn-related muscle wasting, weakness, and functional impairment may occur without fulfilling diagnostic criteria for sarcopenia and represent distinct, clinically relevant manifestations of impaired muscle health. Sarcopenia assessment in burn patients is challenging and should be individualized according to clinical context and stage of recovery. Preservation and recovery of muscle health should be addressed throughout burn care through individualized nutritional support, early mobilization, and progressive exercise, with pharmacological strategies playing an adjunctive role. Prospective longitudinal studies are needed to characterize muscle-health trajectories, distinguish sarcopenia from other forms of post-burn muscle dysfunction, and determine their prognostic significance and response to interventions, including effects on functional recovery, independence, and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.